Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of skin cancer after conversion to sirolimus-based immunosuppression
2006-001528-38Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sirolimus in cutaneous malignancy, actinic keratosis (AK), basal cell carcinoma (BCC) and 1 more, sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Incidence/recurrence of skin cancer. Started Oct 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
cutaneous malignancyactinic keratosis (AK)basal cell carcinoma (BCC)cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on 2006-001528-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001528-38.